Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellum | 3 | 2025 | 440 | 0.880 |
Why?
|
| Thalamus | 1 | 2025 | 85 | 0.850 |
Why?
|
| Dystonic Disorders | 1 | 2025 | 97 | 0.810 |
Why?
|
| Deep Brain Stimulation | 1 | 2025 | 441 | 0.610 |
Why?
|
| Phage Therapy | 3 | 2025 | 52 | 0.550 |
Why?
|
| Bacteriophages | 3 | 2025 | 97 | 0.530 |
Why?
|
| Dystonia | 2 | 2025 | 169 | 0.400 |
Why?
|
| Mutism | 2 | 2024 | 29 | 0.390 |
Why?
|
| Cerebellar Neoplasms | 2 | 2024 | 323 | 0.310 |
Why?
|
| Medulloblastoma | 2 | 2024 | 388 | 0.300 |
Why?
|
| Klebsiella pneumoniae | 2 | 2024 | 86 | 0.250 |
Why?
|
| Olivary Nucleus | 1 | 2025 | 14 | 0.240 |
Why?
|
| Burkholderia | 1 | 2025 | 6 | 0.230 |
Why?
|
| Burkholderia Infections | 1 | 2025 | 8 | 0.230 |
Why?
|
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2024 | 6 | 0.220 |
Why?
|
| Sputum | 1 | 2025 | 115 | 0.220 |
Why?
|
| Klebsiella Infections | 1 | 2024 | 61 | 0.210 |
Why?
|
| beta-Lactamases | 2 | 2024 | 218 | 0.210 |
Why?
|
| Movement | 1 | 2025 | 143 | 0.210 |
Why?
|
| Neutropenia | 1 | 2024 | 202 | 0.200 |
Why?
|
| Cystic Fibrosis | 1 | 2025 | 267 | 0.190 |
Why?
|
| Gene Ontology | 1 | 2021 | 53 | 0.180 |
Why?
|
| Crowdsourcing | 1 | 2021 | 14 | 0.180 |
Why?
|
| Cerebellar Diseases | 1 | 2022 | 73 | 0.170 |
Why?
|
| Rhodococcus | 1 | 2020 | 2 | 0.170 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 151 | 0.170 |
Why?
|
| Biofuels | 1 | 2020 | 12 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2024 | 431 | 0.170 |
Why?
|
| Myasthenia Gravis | 1 | 2021 | 31 | 0.170 |
Why?
|
| Language Development Disorders | 1 | 2022 | 177 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4664 | 0.160 |
Why?
|
| Salmonella Phages | 1 | 2019 | 2 | 0.160 |
Why?
|
| DNA Packaging | 1 | 2019 | 4 | 0.160 |
Why?
|
| Salmonella | 1 | 2019 | 31 | 0.160 |
Why?
|
| Rats | 1 | 2025 | 3412 | 0.140 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 327 | 0.140 |
Why?
|
| Coronary Disease | 1 | 2022 | 637 | 0.140 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2017 | 4 | 0.140 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2017 | 14 | 0.130 |
Why?
|
| Acinetobacter Infections | 1 | 2017 | 33 | 0.130 |
Why?
|
| Acinetobacter baumannii | 1 | 2017 | 45 | 0.130 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 39 | 0.130 |
Why?
|
| Shift Work Schedule | 1 | 2017 | 29 | 0.120 |
Why?
|
| Occupational Diseases | 1 | 2017 | 79 | 0.120 |
Why?
|
| Thymocytes | 1 | 2015 | 10 | 0.120 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2015 | 8 | 0.120 |
Why?
|
| Lymphopenia | 1 | 2015 | 34 | 0.120 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 441 | 0.110 |
Why?
|
| Thymus Gland | 1 | 2015 | 100 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 2551 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2015 | 347 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 500 | 0.090 |
Why?
|
| Body Weight | 1 | 2015 | 988 | 0.090 |
Why?
|
| Animals | 4 | 2025 | 33899 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2099 | 0.070 |
Why?
|
| Male | 5 | 2025 | 64557 | 0.060 |
Why?
|
| Humans | 12 | 2025 | 130574 | 0.060 |
Why?
|
| Bacterial Translocation | 1 | 2024 | 24 | 0.060 |
Why?
|
| Azabicyclo Compounds | 1 | 2024 | 26 | 0.050 |
Why?
|
| Carbapenems | 1 | 2024 | 45 | 0.050 |
Why?
|
| Ceftazidime | 1 | 2024 | 49 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2024 | 278 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3835 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 843 | 0.040 |
Why?
|
| Mice | 3 | 2025 | 18224 | 0.040 |
Why?
|
| Emotions | 1 | 2024 | 350 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 2021 | 10 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3114 | 0.040 |
Why?
|
| Solvents | 1 | 2020 | 42 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 958 | 0.040 |
Why?
|
| Lipoprotein(a) | 1 | 2022 | 140 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 241 | 0.040 |
Why?
|
| Research | 1 | 2022 | 266 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 87 | 0.040 |
Why?
|
| Siphoviridae | 1 | 2019 | 3 | 0.040 |
Why?
|
| Virion | 1 | 2019 | 116 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1159 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 506 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2019 | 157 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 341 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2019 | 451 | 0.030 |
Why?
|
| Kidney | 1 | 2024 | 1283 | 0.030 |
Why?
|
| Triglycerides | 1 | 2020 | 604 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2019 | 339 | 0.030 |
Why?
|
| Gallstones | 1 | 2017 | 18 | 0.030 |
Why?
|
| Child | 3 | 2024 | 26145 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 357 | 0.030 |
Why?
|
| Minocycline | 1 | 2017 | 43 | 0.030 |
Why?
|
| Phylogeny | 1 | 2019 | 707 | 0.030 |
Why?
|
| Genome | 1 | 2019 | 467 | 0.030 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2017 | 24 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 658 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2017 | 63 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2024 | 14987 | 0.030 |
Why?
|
| Computational Biology | 1 | 2021 | 868 | 0.030 |
Why?
|
| United Kingdom | 1 | 2017 | 253 | 0.030 |
Why?
|
| Proteins | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 153 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Valsartan | 1 | 2015 | 26 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 48 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 62 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 118 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 13306 | 0.030 |
Why?
|
| Female | 4 | 2024 | 70509 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 73 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2015 | 130 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 80 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 167 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 297 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2201 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 198 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2844 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20774 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17653 | 0.030 |
Why?
|
| Actins | 1 | 2015 | 314 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5085 | 0.020 |
Why?
|
| Life Style | 1 | 2015 | 447 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 868 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1625 | 0.020 |
Why?
|
| Genomics | 1 | 2019 | 1622 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 475 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 1246 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2017 | 891 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3189 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1849 | 0.020 |
Why?
|
| Aged | 2 | 2017 | 20925 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3816 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10993 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1423 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 2389 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12891 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 6475 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 28448 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31202 | 0.010 |
Why?
|